The effectiveness of mebicar in chronic coronary heart disease
R. A. Kamburg , D. A. Valimukhametova
Kazan medical journal ›› 1984, Vol. 65 ›› Issue (6) : 424 -426.
The effectiveness of mebicar in chronic coronary heart disease
Modern pharmacotherapy of chronic coronary heart disease (HIBS) is based on the use of two main groups of drugs — nitrates and beta-blockers. The effectiveness of other drugs in the complex treatment of this disease is being reviewed and constantly debated [1, 2]. The treatment of HIBS, combined with bradycardia, circulatory insufficiency, bronchospastic conditions, intolerance or contraindications to the use of nitrates and beta-blockers, is a great difficulty.
| [1] |
Гасилин В. С., Сидоренко Б. А. Стенокардия. М., Медицина, 1981. |
| [2] |
Горлин Р. Болезни коронарных артерий. М., Медицина, 1980. |
| [3] |
3имакова И. Е., Камбург Р. А., Киршин С. В. Фармакол. и токсикол., 1980, 4 |
| [4] |
Камбург Р. А., Зимакова И. Е. Там же, 1982, 4. |
| [5] |
Халфен Э. Ш. Ишемическая болезнь сердца. М., Медицина, 1972. |
Eco-Vector
/
| 〈 |
|
〉 |
PDF
